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http://dxObjectives: To determine the preoperative and perioperative risk factors that significantly predict adverse
outcomes after total arch replacement in patients with previous proximal aortic surgery and to analyze patient
survival.
Methods: We performed univariate analysis and logistic regression on data extracted from a prospectively
maintained database for 119 patients who had undergone total arch operations during a 7.5-year period. All
patients had undergone previous proximal aortic surgery. The adverse outcome was defined as a single compos-
ite endpoint comprising operative mortality, permanent neurologic deficit, and renal failure necessitating
permanent hemodialysis.
Results: The incidence of the composite endpoint was 13.5% (16 of 119 patients). The univariate predictors
were preoperative pulmonary disease (P¼ .010), cardiac ischemia time (P¼ .032), and cardiopulmonary bypass
(CPB) time (P ¼ .073). On multivariate analysis, the following were predictors of the composite endpoint:
preoperative pulmonary disease (P ¼ .036), CPB time (P ¼ .039), concomitant coronary artery bypass
(P ¼ .0057), previous aortic valve replacement (P ¼ .027), and previous thoracoabdominal aortic aneurysm
surgery (P ¼ .057). Multivariate analysis showed that the CPB time predicted mortality (P ¼ .0044), and
previous thoracoabdominal aortic aneurysm surgery predicted stroke (P ¼ .034). The overall survival was
85.3% during a median follow-up of 4.76 years (95% confidence interval, 4.2-5.1).
Conclusions: Aortic arch reoperations, although technically demanding, can produce acceptable results.
Preoperative pulmonary disease, CPB time, and concomitant coronary artery bypass predicted an adverse
outcome. The CPB time predicted mortality, and previous thoracoabdominal aortic surgery predicted stroke.
(J Thorac Cardiovasc Surg 2014;148:2967-72)A
C
DSince Cooley and colleagues1 reported the first aortic arch
replacement in 1955, the strategies for brain protection
have significantly advanced and surgical techniques
have been refined, leading to improved perioperative rates
of death and neurologic events.2,3 The application of
hypothermia in aortic surgery, introduced by Griepp and
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The Journal of Thoracic and Carsurgeons’ ability to perform complex aortic arch reconstruc-
tion. Other new techniques introduced during the past
decade have included the use of antegrade cerebral perfu-
sion by Kazui and colleagues5 for brain protection and the
flexible alternative to the island technique by Spielvogel
and colleagues.6 Despite these improvements, aortic arch
surgery has remained challenging. Reoperation of the aortic
arch, especially in patients with previous proximal aortic
surgery, is one of the most complicated and technically
demanding operations and requires a surgical team with
expertise and experience. In the published data, the preoper-
ative and intraoperative risk factors have been described in
relatively large series of first-time operations of the aortic
arch. In the present study, we identified the preoperative
and intraoperative risk factors for patients undergoing
extended aortic arch operations who had undergone previ-
ous proximal aortic surgery, evaluated the adverse outcomes
in this group, and performed a survival analysis.METHODS
From January 2005 to August 2013, 119 consecutive patients with pre-
vious proximal aortic surgery underwent reoperation for total aortic archdiovascular Surgery c Volume 148, Number 6 2967
Abbreviations and Acronyms
ACP ¼ antegrade cerebral perfusion
CABG ¼ coronary artery bypass grafting
CPB ¼ cardiopulmonary bypass
ET ¼ elephant trunk
LCCA ¼ left common carotid artery
TAAA ¼ thoracoabdominal aortic aneurysm
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Dreplacement at our institution. The only patients excluded were those
whose previous surgery was aortic valve replacement or coronary artery
bypass grafting (CABG). The mean patient age was 55.4 13.7 years,
and most weremen (n¼ 89, 74.8%). The institutional review board at Bay-
lor College of Medicine approved the present study. The data were
collected and analyzed from a prospectively maintained clinical database.
The patients’ preoperative characteristics and demographic data are listed
in Table 1, and the association with the composite endpoint is presented in
Table 2.
Study Design, Variables, and Adverse Outcome
The medical records, surgical diagrams, and operative reports were
reviewed to verify the collected data. The follow-up data were obtained
from the clinic visits, hospital medical records, Social Security Death
Index, and telephone interviews with the patient. The adverse outcome
was defined as a single composite endpoint that included operative mortal-
ity, permanent neurologic deficit, and renal failure necessitating hemodial-
ysis at discharge. A permanent neurologic deficit was defined as stroke
(new brain injury evident either clinically or radiographically after the
procedure) or paraplegia. Operative mortality was defined as death within
30 days postoperatively or before hospital discharge. Preoperative pulmo-
nary disease was defined as a history of restrictive or obstructive (history of
asthma, chronic bronchitis, or emphysema) lung disease. We have previ-
ously defined our intraoperative times.7 In brief, the cardiopulmonary
bypass (CPB) time was defined as the period in which the patient was
receiving cardiopulmonary support, not including the circulatory arrest
time. The antegrade cerebral perfusion (ACP) time was defined as the
period of circulatory arrest during which the patient was receiving ACP.
The circulatory arrest time was defined as the ACP time plus the cerebral
circulatory arrest time (period without ACP). The myocardial ischemia
time was the interval from the initiation of the circulatory arrest time (no
patients received crossclamping before circulatory arrest) until clamp
removal and restoration of coronary flow. As a part of the preoperative
workup, the patients had undergone computed tomography, with or without
contrast, depending on their renal function, to assess the proximity of the
cardiac structures to the sternum.
Operative Technique
All patients had had previous surgery in the ascending aorta and/or
proximal arch or the total arch. Of the 119 patients, 16 (13.5%) had under-
gone>1 previous sternotomy. The procedural details and concomitant
procedures are listed in Table 3, and the association of the intraoperative
variables and the composite endpoint is presented in Table 4.
For arterial inflow for CPB, we used the right axillary artery (n ¼ 107,
89.9%), innominate artery (n ¼ 7, 5.9%), carotid artery (n ¼ 4, 3.4%), or
femoral artery (n ¼ 1, 0.8%). An 8-mm Dacron graft was attached
end-to-side with a running 6.0 Prolene suture to the right axillary artery,
innominate artery,7 and/or right or left carotid artery after 1 mg/kg of
heparin was given, and the graft was connected to the arterial line. After
lysis of any adhesions, CPBwas initiated, with cooling to a nasopharyngeal
temperature of 21C to 24C. During the entire procedure, we monitored
the near-infrared spectroscopy signal.7 Of the 76 patients (63.9%) who2968 The Journal of Thoracic and Cardiovascular Surunderwent total aortic arch replacement with the elephant trunk (ET)
procedure, classic ET repair was used in 66 and frozen ET in 10. The aortic
arch repair was performed using different reconstruction techniques
(Tables 3 and 4). For the Y-graft aortic arch repair, we used a
prefabricated or a self-made bifurcated (Y-graft, n ¼ 46), trifurcated
(double Y-graft, n¼ 28), and a single graft (n¼ 4; Vascutek; Terumo, Ren-
frewshire, Scotland). The most common diameter of the main trunk of the
Y-graft used was 12 mm; that of the side branches was usually 8 or 10 mm.
The traditional island technique for arch repair was used in 20 patients
(16.8%), with reimplantation of 3 (n ¼ 15 patients) or reimplantation of
2 (n ¼ 5 patients) vessels. A multibranch graft was used in 12 patients
(10.1%). Finally, a combination of the island technique and the Y-graft
technique was used in 9 patients (7.6%). We have previously described
our technique using the Y-graft.2 In brief, during cooling, the brachioce-
phalic vessels were exposed, and the trifurcated graft was sutured first to
the left subclavian artery and then to the left common carotid artery
(LCCA). Occasionally, depending on the anatomy, a single 8- to 12-mm
graft was attached into the left subclavian artery, followed by attachment
of the Y-graft to the LCCA.2 When using the bifurcated or trifurcated graft
technique, the reconstruction always started distally with reconstruction of
the subclavian artery first and then moved proximally toward reconstruc-
tion of the LCCA. When the targeted temperature had been achieved,
circulatory arrest was initiated with ACP (flow 10 mL/kg/min), which
was adjusted according to the near-infrared spectroscopic findings. A
decrease in the near-infrared spectroscopy regional cerebral oxygen satura-
tion reading of>10% from the patient’s baseline measurement prompted
us to increase the flow to 13 to 15 mL/kg/min. ACP can be administered
by way of the branches of the Y-graft. The innominate artery is transected
and anastomosed to the main trunk of the bi- or trifurcated graft. After
completion of the anastomosis of the head vessels, a clamp was usually
placed to the proximal aspect of the graft to direct the flow from the right
axillary artery or the innominate artery to the other head vessels. If patho-
logic features extended beyond the left subclavian, we performed an ET
repair using a skirted ET graft (Vascutek; Terumo). In patients in whom
the frozen ET technique was used, the stent graft was delivered antegrade
under direct vision and over a stiff Amplatz wire (Boston Scientific, Marl-
borough, Mass).8 With the Y-graft approach, unlike the island technique,
the distal anastomosis to the arch, even when the ET technique is used,
can be performed proximally at the level of the innominate or LCCA,
reducing the risk to the recurrent laryngeal nerve and allowing for
simplified access for hemostasis.Statistical Analysis
For univariate analysis, to test for significant differences between the 2
groups, we used the Student t test for continuous variables and the
chi-square test, or Fisher’s exact test when necessary, for categorical
variables. Nominal logistic regression was performed. The following 19
preoperative and intraoperative variables were used for the multivariate
logistic regression analysis: age, sex,>1 previous sternotomy, emergency,
preoperative pulmonary disease, renal failure, preoperative stroke, preoper-
ative CABG or percutaneous transluminal coronary angioplasty, previous
surgery aortic root, previous transverse arch surgery, previous proximal
arch surgery, previous aortic valve replacement surgery with concomitant
proximal aortic surgery, previous thoracoabdominal aortic aneurysm
(TAAA) surgery, circulatory arrest time, CPB time, cardiac ischemia
time, concomitant CABG, concomitant aortic root surgery, and concomi-
tant aortic valve surgery. To determine what other variables were close to
being predictors of the outcome measures, a sensitivity analysis was
performed by changing the limits on the P values required for a variable
to both enter and stay in the model. When the entry value was set at
P ¼ .3 and the stay value was set at P ¼ .1, different variables were shown
to contribute to the outcomes.
Survival functions were estimated using the Kaplan-Meier method. The
interval to death from the date of the surgery was computed for patientsgery c December 2014
TABLE 1. Preoperative patient characteristics and demographics
Variable Value
Age 55.4  13.7
Male sex 89 (74.8)
Urgent/emergency surgery 14 (11.8)
>1 Previous sternotomy 16 (13.5)
Preoperative pulmonary disease 47 (39.5)
Preoperative renal insufficiency (creatinine  1.5 mg/dL) 24 (20.2)
History of stroke 16 (13.5)
History of percutaneous balloon angioplasty 5 (4.2)
Previous surgery
Ascending with or without proximal arch replacement 112 (94.1)
Aortic root replacement 55 (46.2)
Thoracoabdominal aortic replacement 26 (21.9)
Aortic valve replacement þ proximal aortic surgery* 17 (14.3)
Coronary artery bypass graft þ proximal aortic surgery* 11 (9.2)
Transverse arch replacementy 7 (5.9)
Data presented as mean  standard deviation for continuous variables and n (%) for
categorical variables. Preoperative pulmonary artery disease significant for mortality
only (P ¼ .0136), and previous thoracoabdominal aortic replacement significant for
stroke only (P¼ .040). *Patients with previous aortic valve replacement or repair only
or CABG only were not included in our study. yThree of these patients had pseudoa-
neurysm at the island anastomosis site, 3 had infection of a previously placed arch
graft, and 1 had fusiform aneurysm after previous patch repair of the arch.
TABLE 2. Preoperative variables and association with composite
endpoint (operative mortality, permanent neurologic deficit, renal









Male sex 77 (74.8) 12 (75.0) 1.00
Urgent/emergency surgery 11 (10.7) 3 (18.8) .40
>1 Previous sternotomy 14 (13.6) 2 (12.5) 1.00
Preoperative pulmonary disease 36 (35.0) 11 (68.8) .010
Preoperative renal insufficiency
(creatinine  1.5 mg/dL)
21 (20.4) 3 (18.8) 1.00
History of stroke 15 (14.6) 1 (6.3) .69
History of percutaneous balloon
angioplasty
5 (4.9) 0.(0.0) 1.00
Previous surgery
Ascending with or without proximal
arch replacement
97 (94.2) 15 (93.8) 1.00
Aortic root replacement 50 (48.5) 5 (31.3) .20
AVR or repair 13 (12.6) 4 (25.0) .24
Thoracoabdominal aortic replacement 20 (19.4) 6 (37.5) .10
AVR or repair þ proximal aortic
surgery*
13 (12.6) 4 (25.0) .24
Coronary artery bypass þ
proximal aortic surgery*
8 (7.8) 3 (18.8) .17
Transverse arch replacement or
repairy
7 (6.8) 0 (0.0) .59
Preventza et al Acquired Cardiovascular Diseasewho had died before November 30, 2013. All statistical analyses were
conducted using Statistical Analysis Systems, version 9.1 (SAS Institute,
Inc, Cary, NC).Age (y) for composite 55.2  14.1 57.3  11.5 .56
Data presented as mean  standard deviation for continuous variables and n (%) for
categorical variables. Preoperative pulmonary artery disease significant for mortality
only (P ¼ .0136), and previous thoracoabdominal aortic replacement significant for
stroke only (P ¼ .040). AVR, Aortic valve replacement. *Patients with previous AVR
or repair only or CABG only were not included in our study. yThree of these patients
had pseudoaneurysm at the island anastomosis site, 3 had infection of a previously





Of the 119 patients included in the present study, 10
(8.4%) died in hospital, 2 of whom had undergone urgent
surgery (P ¼ .33; Table 5). Of these 10 patients, 3 died of
heart failure and had been unable to be weaned off ventric-
ular assist support and extracorporeal membrane oxygen-
ator; 3 died of multiorgan failure; 1 had had an extensive
stroke; 1 died of a ruptured thoracoabdominal aneurysm
while waiting for a stage II ET procedure; and 2 underwent
unsuccessful cardiopulmonary resuscitation for hypo-
tension and unresponsiveness on day 44 and 12. Univariate
analysis showed that among the preoperative and
intraoperative variables, preoperative pulmonary disease
(P ¼ .0136), CPB (P ¼ .051), and cardiac ischemia time
(P ¼ .0045) were significant predictors of mortality. In
addition, concomitant CABG was marginally associated
with mortality (P ¼ .063). In the multivariate logistic
regression model, only CPB time remained a predictor of
operative mortality (P ¼ .0044).Neurologic Events
Seven patients (5.9%) experienced a permanent stroke,
and two (1.7%) experienced paraplegia (Table 5). The
cumulative permanent neurologic deficit was 7.6%. On uni-
variate analysis, preoperative TAAA surgery was associated
with stroke (P ¼ .040). In the logistic regression analysisThe Journal of Thoracic and Carmodel, previous TAAA surgery remained an independent
risk factor for stroke (P ¼ .034).
Composite Endpoint
A total of 16 patients (13.5%) had a composite endpoint
comprising operative mortality, permanent neurologic
deficit, and renal failure requiring hemodialysis at discharge
(Table 5). Of these patients, 3 underwent emergency sur-
gery (P ¼ .40). The association between the preoperative
and intraoperative variables and the composite endpoint is
presented in Tables 2-4. Multivariate logistic regression
analysis (Table 6) showed that preoperative pulmonary dis-
ease and concomitant CABG were risk factors for the com-
posite endpoint (P ¼ .020 and P ¼ .0099, respectively). An
additional sensitivity analysis showed that CPB time,
concomitant CABG, preoperative pulmonary dysfunction,
and previous aortic valve replacement were independent
predictors of the composite endpoint (P ¼ .039,
P ¼ .0057, P ¼ .036, and P ¼ .027, respectively). In addi-
tion, previous surgery for TAAA was associated with the
composite endpoint (P ¼ .053).diovascular Surgery c Volume 148, Number 6 2969
TABLE 5. Short-term outcomes (n ¼ 119)
Outcome n (%)
Operative mortality* 10 (8.4)
Postoperative stroke 7 (5.9)
Paraplegia 2 (1.7)
Neurologic deficit (stroke or paraplegia)* 9 (7.6)
Permanent renal failure 1 (0.8)
Composite (mortality, neurologic deficit, permanent
renal failure)
16 (13.5)
Postoperative tracheostomy 21 (17.7)
Reoperation for bleeding 16 (13.5)
Postoperative myocardial infarct 3 (2.5)
Data presented as n (%). *Some of the patients had>1 complication.
TABLE 3. Operative details and concomitant procedures (n ¼ 119)
Variable n (%) or mean ± SD
Aortic arch repair 119 (100)
With elephant trunk 76 (63.9)
Arch reconstruction
Y-graft 46 (38.7)
Trifurcated (double Y) graft 28 (23.5)
Single graft 4 (3.4)
Island anastomosis 20 (16.8)
Multibranch graft 12 (10.1)
Combination of island and Y-graft 9 (7.6)
Aortic root replacement 15 (12.6)
Aortic valve replacement 14 (11.8)
CABG 12 (10.1)
Mitral valve repair 1 (0.8)
Tricuspid valve repair 1 (0.8)
CBP time (min) 153.0  66.4
Circulatory arrest time (min) 73.0  34.6
Cardiac ischemia time (min) 96.5  47.4
SD, Standard deviation; CABG, coronary artery bypass grafting; CPB, cardiopulmo-
nary bypass.
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DThe other postoperative complications and the composite
adverse outcome are listed in Table 5. Figure 1 shows the
Kaplan-Meir survival curve for the follow-up period. The
median follow-up period was 4.76 years (95% confidence
interval, 4.2-5.1). Survival was 91.5% at 1.6 years,
89.3% at 2.4 years, and 88.1% at 3 years.DISCUSSION
Complex aortic arch repair, especially in the reoperative
setting, is one of the most challenging cardiovascular oper-
ations today and carries a significant risk of mortality and
stroke. For such patients, an important concern beyond sur-
viving the surgery is whether they will be able to return to
normal function or will have significant morbidity. In the
present report, we analyzed adverse outcomes as a single
composite endpoint in patients with prior proximal aorticTABLE 4. Intraoperative variables and association with composite
endpoint (operative mortality, neurologic deficit, renal failure
requiring hemodialysis at discharge)
Variable
Composite endpoint
P valueNo (n ¼ 103) Yes (n ¼ 16)
Aortic root replacement 13 (12.6) 2 (12.5) 1.00
Aortic valve replacement 11 (10.7) 3 (18.8) .40
CABG 7 (6.8) 5 (31.3) .010
CPB time (min) 146.6  58.3 194.5  97.3 .073
Circulatory arrest time (min) 70.5  31.9 89.1  46.5 .14
Cardiac ischemia time (min) 92.8  45.5 120.1  53.9 .032
Data presented as mean  standard deviation for continuous variables and n (%) for
categorical variables. CPB time significant for mortality only (P ¼ .051); cardiac
ischemia time significant for mortality only (P ¼ .0045); and CABG almost
significant for mortality (P ¼ .063). CABG, Coronary artery bypass grafting;
CPB, cardiopulmonary bypass.
2970 The Journal of Thoracic and Cardiovascular Sursurgery who had undergone a total arch operation. In our
series, the incidence of the composite endpoint was 13.5%.
In a recent series of 145 total arch repairs, Leshnower and
colleagues9 reported excellent results. The overall mortality
was 9.7% (elective, 10.7% vs emergency, 4.3%; P ¼ NS),
the incidence of permanent neurologic event was 2.8%
(with no cases of paraplegia), the transient neurologic event
rate was 5.6%, and the overall incidence of renal failure
requiring dialysis was 2.8%.9 Our composite endpoint
(13.6%) was greater, but our individual adverse event rates
of 8.4% for mortality and 0.8% for renal failure requiring
hemodialysis at discharge were lower. However, our stroke
rate was greater than that reported by Leshnower and
colleagues.9 In their study, 54 patients (37.2%) required
‘‘redo’’ sternotomy and only 23 patients (15.9%) had
undergone previous proximal aortic surgery.9 In a large
series of 1007 consecutive patients reported by the National
Cerebral and Cardiovascular Center in Japan, the
in-hospital death rate was 4.7%, and the overall incidence
of permanent stroke was 3.3%.10 In that study, 764 patients
had undergone total or partial arch surgery and only 38
(3.8%) had undergone redo aortic surgery. Our greater mor-
tality (8.4%) and stroke (5.9%) rates can be explained by
previous proximal aortic surgery in all our patients and
the more complex operations they required. In the Japanese
study, multivariate analysis showed that chronic obstructive
pulmonary disease was an independent risk factor for early
mortality (P ¼ .041), as was concomitant CABG
(P< .001).10 In our study, univariate analysis supported
the findings of the Japanese study, indicating that preopera-
tive pulmonary disease and concomitant CABG were
associated with mortality (P ¼ .010 and P ¼ .010, respec-
tively). Also, in our logistic regression model, pulmonary
dysfunction and concomitant CABG were independent
predictors for the composite endpoint of operative mortal-
ity, permanent neurologic event, and renal failure requiring
hemodialysis at discharge (P¼ .036 and P¼ .0057, respec-
tively; Table 6). In a study of 423 patients who had
undergone arch replacement at Kobe University Hospital,
the overall mortality was 4.5% and that of permanentgery c December 2014
TABLE 6. Multivariate logistic regression analysis results for
composite endpoint (operative mortality, permanent neurologic
deficit, renal failure requiring hemodialysis at discharge), mortality,
and postoperative stroke




Preoperative pulmonary disease .020 4.04 1.25-13.090
CABG .0099 6.13 1.55-24.28
Additional sensitivity analysis
Elective .069 0.19 0.032-1.14
Preoperative pulmonary disease .036 4.15 1.10-15.66
Previous AVR or repair .027 6.00 1.23-29.22
Previous surgery for TA pathologic
features
.057 3.67 0.96-14.10
CPB time .039 1.01 1.00-1.016
CABG .0057 9.14 1.90-43.85
Mortality
CPB time .0044 1.012 1.004-1.020
Postoperative stroke
Previous surgery for TA pathologic
features
.034 5.46 1.14-26.162
OR, Odds ratio;CI, confidence interval;AVR, aortic valve replacement;TA, thoracoab-
dominal; CPB, cardiopulmonary bypass; CABG, coronary artery bypass grafting.
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Dneurologic injury was 3.3%.3 However, no information was
given regarding previous sternotomy or aortic surgery.11
Zierer and colleagues11 conducted a large study of 1002
patients, 318 (32%) of whom had undergone total arch
replacement and 10% of the entire group had had previous
cardiac operations. They reported that early mortality, per-
manent neurologic outcome, and renal failure necessitating
hemofiltration was 5%, 3%, and 4%, respectively, in the
total group, which included hemiarch and total archFIGURE 1. Kaplan-Meier survival curve for 109 surviving patients aft
The Journal of Thoracic and Carprocedures.11 Although their study was large, the overall
number of patients who had previously undergone
sternotomy was relatively small, they included all previous
cardiac operations, and they did not provide separate data
for the total arch group. Nevertheless, Zierer and
colleagues11 found that a history of stroke was an indepen-
dent predictor for permanent neurologic injury. However,
our results did not support this finding. In our study,
previous surgery for thoracoabdominal pathologic findings
was an independent risk factor for permanent stroke
(P ¼ .034) and was associated with the composite endpoint
(P¼ .057). This can be explained because the patients with
previous thoracoabdominal surgery had more extensive
disease and a greater incidence of atheromatous aorta. In
a study of 636 consecutive patients who underwent partial
or total aortic arch surgery (217 total arches), the investiga-
tors at the Leipzig Heart Center reported that overall early
mortality was 11% and that of permanent neurologic injury
was 11%.12 In their study, 15.7% of the entire group had
had previous cardiac surgery; however, the data for the
previous proximal aortic surgery were not given.12 Their
multivariate analysis showed that total arch replacement
was an independent predictor of mortality and stroke. In
addition, the CPB time was an independent factor for early
mortality. We also found that the CPB time was an indepen-
dent predictor for early mortality (P¼ .0044). Furthermore,
the CPB time has been shown by others to be an indepen-
dent risk factor for mortality.13,14 The CPB time was also
associated with the composite endpoint (P ¼ .039) in our
multivariate analysis.15 In an excellent study by Leonytev
and colleagues15 at Mount Sinai, of 100 patients who under-
went reoperative transverse arch procedures, mortality was
greater during the first year after reoperation than that forer hospital discharge, of whom 93 survived to the end of the study.
diovascular Surgery c Volume 148, Number 6 2971
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Dpatients undergoing primary arch surgery. However, the
long-term survival did not differ between the patients who
had undergone primary arch surgery and those who had
undergone arch reoperation.15 They reported that chronic
obstructive pulmonary disease was also an independent
risk factor for mortality after arch replacement.15 Patel
and colleagues14 conducted an analysis of 721 patients
who had undergone extended arch repair during a 17-year
period (23 of whom had had previous proximal aortic
surgery, and 85 had had previous aortic valve or root
surgery). They reported a 10-year survival of 65%. In our
study, the median follow-up was 4.76 years, with an
overall survival of 85.3%. Higgins and colleagues16 studied
the long-term outcomes after first-time thoracic aortic
surgery in a population-based study of 1960 patients
(330 arches, not redo) and reported that survival was
77.4% at 5 years for patients who underwent arch repair;
their combined morbidity of mortality and stroke was
13.4%.16
In the cited studies from aortic centers of excellence,
although the number of patients undergoing proximal arch
and total arch replacement was large, the experience with
patients undergoing reoperative total arch surgery with
previous proximal aortic surgery was limited, except for
the Hanover, Michigan, and Mount Sinai groups, which
included 110, 108, and 100 patients, respectively, with
combined previous cardiac and aortic reoperations.13-15
The main limitation of our study was its retrospective
nature, with those inherent biases. Nevertheless, we believe
that reporting the outcomes in this consecutive high-risk
group by focusing on the adverse outcome of a composite
endpoint is important.
To our knowledge, ours is the largest study in the
published data of patients with previous proximal aortic
operation who required total arch replacement with a focus
on the composite endpoint of operative mortality, perma-
nent neurologic deficit, and renal failure requiring hemodi-
alysis at discharge. Our study has demonstrated that
reoperation of the aortic arch after previous proximal aortic
surgery, although technically challenging, is feasible with
acceptable results.2972 The Journal of Thoracic and Cardiovascular SurReferences
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